Time to Can Any Buying of Silgan; Company Appears Vulnerable as People Lose Taste for Food in Cans; Volumes have fallen by about 1% each year over the past decade with consumers buying more fresh food
October 21, 2013 Leave a comment
Time to Can Any Buying of Silgan
Company Appears Vulnerable as People Lose Taste for Food in Cans
JOHN JANNARONE
Oct. 20, 2013 8:48 p.m. ET
Always popular, will SpaghettiOs outlive the metal cans they come in? The question came up recently when Campbell Soup, CPB -0.10% which makes SpaghettiOs, teamed up with Green Mountain Coffee Roasters GMCR +3.60% to offer “fresh brewed soup” in single-serve plastic cups. These could offer a simpler heating method than the stovetop or microwaving. Whether that works out or not, the food-can industry is struggling. Volumes have fallen by about 1% each year over the past decade, says the Can Manufacturers Institute. Headwinds include weak demand for soup and consumers buying more fresh food.One company that looks vulnerable is Silgan Holdings, SLGN +0.01% which accounts for half the U.S. food-can market. Silgan also makes plastic containers and tops, but the vast majority of its revenue and profit come from the food-can business.
This year, Europe’s Ardagh Group entered the U.S. market and won a contract withConAgra Foods. CAG -0.51% Analysts say Ardagh agreed to be paid much less than rivals would usually get. Such competitive pressure could squeeze Silgan’s margins, which already look ripe to fall. Analysts forecast an operating margin of 9.6% in 2013, just shy of its all-time peak.
Silgan has its strengths, such as an impressive history of buying smaller rivals and improving them. Resulting synergies around procurement and negotiating better deals with food companies tend to improve Silgan’s profits.
But there aren’t many targets left, and Silgan’s net debt is nearly 2.5 times earnings before interest, taxes, depreciation and amortization. Any higher would be aggressive for a company facing structural headwinds. The stock trades at 8.6 times next year’s Ebitda, well above its 10-year average of about seven times. Investors should leave it on the shelf
